5-fluorodopa has been researched along with Dyskinesia Syndromes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuriakose, R; Stoessl, AJ | 1 |
| Fujii, N; Goto, I; Hasuo, K; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Otsuka, M; Taniwaki, T | 1 |
| Martin, WR | 1 |
2 review(s) available for 5-fluorodopa and Dyskinesia Syndromes
| Article | Year |
|---|---|
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
Topics: Animals; Biomarkers; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Humans; Magnetic Resonance Imaging; Movement Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Synapses; Tomography, Emission-Computed, Single-Photon | 2010 |
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glucose; Humans; Huntington Disease; Levodopa; Movement Disorders; Oxygen Consumption; Parkinson Disease; Synapses; Tomography, Emission-Computed | 1985 |
1 other study(ies) available for 5-fluorodopa and Dyskinesia Syndromes
| Article | Year |
|---|---|
Positron emission tomography (PET) in "pure akinesia".
Topics: Adult; Aged; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Female; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |